According to Onconova Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.00. In 2022 the company made an earnings per share (EPS) of -$0.91 an increase over its 2021 EPS that were of -$0.97.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.00 | 9.89% |
2022 | -$0.91 | -6.19% |
2021 | -$0.97 | -54.67% |
2020 | -$2.14 | -94.7% |
2019 | -$40.38 | -66.06% |
2018 | -$118.95 | -81.2% |
2017 | -$632.70 | -50.72% |
2016 | -$1,284 | -46.27% |
2015 | -$2,389 | -64% |
2014 | -$6,637 | -20.41% |
2013 | -$8,340 | 69.04% |
2012 | -$4,934 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Baxter BAX | $5.12 | -612.00% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | -$0.36 | -64.00% | ๐บ๐ธ USA |
CTI BioPharma
CTIC | -$0.58 | -42.00% | ๐บ๐ธ USA |
Array Technologies ARRY | $0.51 | -151.00% | ๐บ๐ธ USA |